Navigation Links
Deston Therapeutics Stands By Safety and Efficacy of Auralgan After FDA Action
Date:2/25/2011

CHAPEL HILL, N.C., Feb. 25, 2011 /PRNewswire/ -- Deston Therapeutics LLC ("Deston") announced today that it is currently exploring its options to respond to a recent seizure of its Auralgan Otic Solution ("Auralgan") by the Federal Government and that it still believes that Auralgan is a safe and effective drug product.

"Despite the recent actions by the government, we believe that Auralgan is still a safe and effective treatment for ear pain and inflammation," said David Preston RPh, CEO of Deston.  "Auralgan has a long history of safe marketing and use, the medical literature supports the effectiveness of this product, and the side effects associated with this product are well-known.  The current situation is a result of a misunderstanding between FDA and Deston and not of a product safety concern."

On February 14, 2011, the Federal Government initiated an action in United States District Court of the Western District of Kentucky to condemn shipments of Auralgan located at Deston's distributor asserting that this drug product was a "new drug" that had not received prior approval from the Food and Drug Administration ("FDA") before it was sold.  

"While the government has seized shipments of Auralgan, the current complaint is not directed against Deston, its suppliers, or its distributors," said Edward John Allera, who is Deston's legal counsel, a partner at Buchanan Ingersoll & Rooney PC, a former FDA attorney and an expert in this area. "Instead, the current complaint focuses only on those units of Auralgan held by one distributor."

The central issue in this proceeding is the precise legal status of Auralgan as a "new drug" or an "old drug."  In its pleadings, the Federal Government asserts that Auralgan is a "new drug", but these allegations did not provide any new information regarding the safety or efficacy of Auralgan.  According to Mr. Allera, "The government has not provided any new evidence in i
'/>"/>

SOURCE Deston Therapeutics LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 Thousands of people will peacefully ... the opioid addiction epidemic at dozens of rallies across ... 2008, the United States has ... prescription opioids and heroin, yet the President has never ... worded letter to President Obama , rally organizers ...
(Date:8/31/2015)... ALBANY, New York , August 31, 2015 ... Research report states that the global cardiovascular monitoring ... in 2012 and is predicted to reach a ... at a CAGR of 9.7% between 2013 and ... Monitoring and Diagnostic Devices Market (ECG, Holter Monitors, ...
(Date:8/31/2015)... Pa. , Aug. 31, 2015  The departments ... an event today at Gaudenzia Concept 90 to raise ... drug overdose crisis in Pennsylvania ... treatment and focus on recovery through the Building ... many Pennsylvanians are dying every day to a disease ...
Breaking Medicine Technology:Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2
... MOUNTAIN VIEW, Calif., Aug. 12 As more and more ... spinal surgery techniques, the negatives of the spinal fusion market ... five years, the industry expects to see a steady inflow ... in the market. (Logo:   http://www.medicaldevices.frost.com ), ...
... Nev., Aug. 13 PDL BioPharma, Inc. (PDL) (Nasdaq: ... and the PDL BioPharma logo are considered trademarks of ... This press release contains forward-looking statements. Each ... results may differ materially from those, express or implied, ...
Cached Medicine Technology:Frost & Sullivan: Innovative Products and Technologies Strengthen U.S. Spinal Surgery Market 2PDL BioPharma Receives Letter from Genentech Relating to European Patents 2
(Date:9/1/2015)... ... September 01, 2015 , ... ... 5:00 to 8:00 pm at the Marriott Indianapolis Downtown, 350 West Maryland Street, ... will be attending from across the country. All specialties will be represented. Attendees ...
(Date:9/1/2015)... Vegas, NV (PRWEB) , ... September 01, 2015 ... ... care or Self-Directed Care is, how to access caregivers and what to look ... other valuable and pertinent information. , Founded in 2006 in Canoga Park, CA ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... send information about new patients directly from Practice Perfect to FOTO enabling cost ... entry. , Steven Presement, President of Practice Perfect, stated "FOTO ...
(Date:9/1/2015)... ... September 01, 2015 , ... Routines… every family has them. Whether it’s a ... easier for parents, caregivers and children too. Here are three reasons why routines can ... become more fluid. When a routine is implemented into a child’s schedule, they are ...
(Date:9/1/2015)... ... ... Specialty Technical Publishers (STP) and Specialty Technical Consultants (STC) ... audit protocol for the European Union. Leading companies around the world use IAPC ... rapidly collect, share, archive, and export audit findings in a cost-effective manner. , ...
Breaking Medicine News(10 mins):Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2Health News:FOTO Announces New Integration Partnership with Practice Perfect 2Health News:Back into the Swing of Things: How Family Routines Benefit Children 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 4
... know that exercise is important to maintain and ... are at all-time highs and have become major ... Missouri researchers found that healthy adults who received ... physical activity levels. Conversely, interventions based on cognitive ...
... , THURSDAY, Feb. 17 (HealthDay News) -- People who ... times increased risk of developing Parkinson,s disease, a new ... Parkinson,s disease and 358 people without the nervous system ... Farming and Movement Evaluation Study involving licensed pesticide applicators ...
... A rinsing technique with betadine that costs ... reduce the infection rate following total knee and hip joint ... University Medical Center. The study, presented at the ... a three minute diluted betadine lavage combined with painting of ...
... , THURSDAY, Feb. 17 (HealthDay News) -- Some ... finding that suggests the need for more oversight of ... study. Of 5,156 "tweets" sent by 260 U.S. ... researchers found that 3 percent were unprofessional. ...
... 2011) Two studies published in the current issue ... islet cell transplantation for treating diabetes. Researchers in Milan, ... in diabetic therapy and islet cell regeneration and Canadian ... in vitro. Both studies are in the ...
... (HealthDay News) -- Arthritis affected about 3.1 million Hispanics in ... wide variations in arthritis rates among Hispanic subgroups, according to ... ranged from a low of 11.7 percent among Cuban Americans ... to the analysis of National Health Interview Survey data from ...
Cached Medicine News:Health News:To increase physical activity, focus on how, not why 2Health News:2 Pesticides Linked to Parkinson's in Study 2Health News:Inexpensive rinsing effective at reducing post-op infection following joint replacement surgery 2Health News:Some Docs May Use Twitter for 'Unprofessional' Messages: Report 2Health News:Researchers work at the frontiers of islet cell transplantation 2Health News:Researchers work at the frontiers of islet cell transplantation 3Health News:3.1 Million Hispanic Americans Struggle With Arthritis 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: